Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Neuroprotective agents for clinical trials in ALS: a systematic assessment.

Neuroprotective agents for clinical trials in ALS: a systematic assessment. Neurology. 2006 Jul 11; 67(1):20-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.